UNSPSC 51162403: Acetaminophen/dextromethorphan/guaifenesin/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE514. This VA Drug Class (RE514) classifies this compound as belonging to the group DECONGESTANT/ANTITUSSIVE/EXPECTORANT/ANALGESIC.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162403 Acetaminophen/dextromethorphan/guaifenesin/phenylpropanolamine is a Commodity code covering specific combination over-the-counter pharmaceutical products. Recent state and local procurement activity under this code shows limited direct relevance — the posted opportunities are tagged to the code but actually solicit broader pharmaceutical categories (naloxone and multi-source OTC products generally) rather than this specific drug formulation. State and local health departments, cooperative purchasing alliances, and county health services use this code family to procure generic and OTC medications for community health programs, emergency response, and public health support. The work involves supplying pre-manufactured pharmaceutical products with regulatory compliance (cGMP, DSCSA, FDA approval), managing supply chain documentation (NDC codes, UPCs, SKUs), and coordinating distribution through authorized wholesalers or direct delivery to government health facilities.

Recent opportunities show activity across Florida and Minnesota. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building and a response deadline of July 26, 2026. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 to establish multi-award contracts for generic pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon, with responses due March 26, 2026 and contract effectiveness July 1, 2026. Both procurements require vendor compliance with drug-supply chain regulations, insurance coverage, and submission through government e-procurement portals. The code shows sporadic recent activity; firms should verify direct product relevance when pursuing opportunities tagged to this specific formulation, as broader OTC and generic pharmaceutical RFPs may be mislabeled at the commodity level.